877-202-0205     support@chemchart.com     @chemchart
        
Sign In    Register
   Reset Filters

Pyrimidines, Antineoplastic and immunomodulating drugs, Cardiovascular system drug

Categories

Antineoplastic and immunomodulating drug (1)
Cyclic compounds (1)
Drugs acting on the cardiovascular system (1)
Pharmaceuticals (1)
Six-membered rings (1)

Darusentan (171714-84-4)  
Darusentan (LU-135252; HMR-4005) is an endothelin receptor antagonist. Gilead Colorado, a subsidiary of Gilead Sciences, under license from Abbott Laboratories, is developing darusentan for the potential treatment of uncontrolled hypertension. In June 2003, Myogen licensed the compound from Abbott for its application in the cancer field.
Related searches
Pyrimidines
Antineoplastic and immunomodulating drugs
Cardiovascular system drug